TECOGEN INC.·4

Mar 27, 12:10 PM ET

Lewis Earl 4

4 · TECOGEN INC. · Filed Mar 27, 2026

Research Summary

AI-generated summary of this filing

Updated

TECOGEN (TGEN) Director Lewis Earl Buys 5,000 Shares

What Happened Lewis Earl, a director of TECOGEN, purchased 5,000 shares of TGEN stock on 2026-03-26 at $2.88 per share, for a total transaction value of approximately $14,409. This was a purchase (insider acquisition), which investors often view as a stronger signal than routine sales because it represents the insider adding to their position.

Key Details

  • Transaction date: 2026-03-26 (reported on Form 4 filed 2026-03-27)
  • Trade type/code: Open-market purchase (Code P = Purchase)
  • Shares acquired: 5,000 at $2.88 per share
  • Total value: ~$14,409
  • Shares held after transaction: Not disclosed in this filing
  • Footnote: F1 indicates the shares were acquired by a trust (shares placed in or purchased by a trust for the insider)
  • Filing timeliness: Report filed the next day (timely; no late filing flag)

Context This was a straightforward open-market purchase (not an option exercise, gift, or compensatory award). The acquisition by a trust means the shares are held in a trust vehicle rather than directly in the insider’s name; that structure is common and does not by itself indicate the insider’s intent. No additional holdings or 10% ownership status are reported here, so assess this trade alongside other filings and company-specific news for fuller context.

Insider Transaction Report

Form 4
Period: 2026-03-26
Lewis Earl
Director
Transactions
  • Purchase

    Common Stock

    [F1]
    2026-03-26$2.88/sh+5,000$14,4091,006,006 total
Footnotes (1)
  • [F1]Shares acquired by a trust
Signature
/s/ Earl R. Lewis|2026-03-27

Documents

1 file
  • 4
    wk-form4_1774627831.xmlPrimary

    FORM 4